Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03149029
Brief Title: Abbreviated MAPK Targeted Therapy Plus Pembrolizumab in Melanoma

First Submitted : May 8, 2017
First Submitted that Met QC Criteria : May 10, 2017
First Posted : May 11, 2017

Last Update Submitted that Met QC Criteria : January 18, 2021
Last Update Posted : January 20, 2021